Company intelligence / Profile preview

EB Supplements

Orlando, Florida, United States

Ownership: Private
Development stage: Other

Overview

EB Supplements is a commercial-stage provider of evidence-based dietary supplements. Their flagship product line includes MAG-O3™, an advanced omega‑3 supplement manufactured in Norway with certifications for sustainability and purity. The company emphasizes clinical research partnerships and third-party testing to ensure efficacy and safety. No pharmaceutical clinical trial results are reported; products are marketed as dietary supplements for general wellness rather than disease treatment[1][2].

Therapeutic areas: NeurologyEndocrinologyOtherImmunologyCardiovascular
Modalities: Small molecule (vassitamins, minerals, nutraceuticals)Biologic (fish oil/omega 3)
Industry: Food & Nutrition

Partnerships

Collaborations with universities/research organizations for clinical research[2]. Specific partners not named.

Beyond the preview

Go deeper on EB Supplements.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EB Supplements.

Explore the full profile